Sign Up to like & get
recommendations!
0
Published in 2019 at "Hematological Oncology"
DOI: 10.1002/hon.35_2629
Abstract: tal response in stage IB/IIA demonstrates meaningful clinical benefit with MOGA in early stage MF pts previously treated with systemic therapies despite MAVORIC not being powered to determine treatment effect by disease stage. Sponsor: Kyowa…
read more here.
Keywords:
phase evaluation;
response;
trial phase;
stage ... See more keywords